State of New Jersey Common Pension Fund D Sells 1,925 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of New Jersey Common Pension Fund D reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 7.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 25,457 shares of the company’s stock after selling 1,925 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.05% of Prestige Consumer Healthcare worth $1,988,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Huntington National Bank boosted its stake in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after purchasing an additional 181 shares in the last quarter. International Assets Investment Management LLC increased its holdings in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares during the last quarter. Covestor Ltd increased its holdings in shares of Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company’s stock worth $96,000 after acquiring an additional 654 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Prestige Consumer Healthcare by 102.4% in the third quarter. Blue Trust Inc. now owns 1,755 shares of the company’s stock worth $121,000 after acquiring an additional 888 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on PBH. DA Davidson upped their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research report on Monday, December 9th. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, Canaccord Genuity Group increased their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $92.60.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $84.66 on Monday. The stock has a fifty day simple moving average of $79.47 and a two-hundred day simple moving average of $76.62. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $88.36. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 19.83, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.